世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032854

セリアック病治療薬の世界市場(2022-2026)

TechNavio

Global Celiac Disease Drugs Market 2022-2026

発刊日 2022/07/29

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000032854

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、セリアック病治療薬市場を分析します。

世界のセリアック病治療薬市場は、予測期間中に約16.95 %のCAGRで推移し、2022年から2026年の間に6億157万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。この市場は、グルテンを含む食品の消費量の増加、セリアック病の罹患率の増加、政府の取り組みなどによって牽引されています。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ 第1選択の治療
      ◇ 第2選択の治療
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、今後数年間のセリアック病治療薬市場の成長を促進する主要な理由の一つとして、無機的な成長戦略を挙げています。また、強力なパイプラインと医薬品支出の増加は、市場の大きな需要につながるでしょう。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • セリアック病治療薬の市場規模
  • セリアック病治療薬の市場予測
  • セリアック病治療薬市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なセリアック病治療薬市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ 9 Meters Biopharma Inc.
    ➣ Adaptive Biotechnologies Corp.
    ➣ Almirall SA, Amgen Inc.
    ➣ AMYRA Biotech AG
    ➣ Avaxia Biologics Inc.
    ➣ BioLineRx Ltd.
    ➣ Bristol Myers Squibb Co.
    ➣ Calypso Biotech
    ➣ GlaxoSmithKline Plc
    ➣ Glenmark Pharmaceuticals Ltd
    ➣ Immunogenics LLC
    ➣ Johnson and Johnson
    ➣ Precigen Inc.
    ➣ Sanofi
    ➣ Takeda Pharmaceutical Co. Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Vactech Oy
    ➣ Zedira GmbH
    ➣ Artielle Immunotherapeutics Inc.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Therapy
5.1 Market segments
Exhibit 24: Chart on Therapy - Market share 2021-2026 (%)
Exhibit 25: Data Table on Therapy - Market share 2021-2026 (%)
5.2 Comparison by Therapy
Exhibit 26: Chart on Comparison by Therapy
Exhibit 27: Data Table on Comparison by Therapy
5.3 First line treatment - Market size and forecast 2021-2026
Exhibit 28: Chart on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on First line treatment - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on First line treatment - Year-over-year growth 2021-2026 (%)
5.4 Second line treatment - Market size and forecast 2021-2026
Exhibit 32: Chart on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Second line treatment - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Second line treatment - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Therapy
Exhibit 36: Market opportunity by Therapy ($ million)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Amgen Inc.
Exhibit 85: Amgen Inc. - Overview
Exhibit 86: Amgen Inc. - Product / Service
Exhibit 87: Amgen Inc. - Key offerings
10.4 AMYRA Biotech AG
Exhibit 88: AMYRA Biotech AG - Overview
Exhibit 89: AMYRA Biotech AG - Product / Service
Exhibit 90: AMYRA Biotech AG - Key offerings
10.5 BioLineRx Ltd.
Exhibit 91: BioLineRx Ltd. - Overview
Exhibit 92: BioLineRx Ltd. - Product / Service
Exhibit 93: BioLineRx Ltd. - Key offerings
10.6 Bristol Myers Squibb Co.
Exhibit 94: Bristol Myers Squibb Co. - Overview
Exhibit 95: Bristol Myers Squibb Co. - Product / Service
Exhibit 96: Bristol Myers Squibb Co. - Key offerings
10.7 Calypso Biotech
Exhibit 97: Calypso Biotech - Overview
Exhibit 98: Calypso Biotech - Product / Service
Exhibit 99: Calypso Biotech - Key offerings
10.8 GlaxoSmithKline Plc
Exhibit 100: GlaxoSmithKline Plc - Overview
Exhibit 101: GlaxoSmithKline Plc - Business segments
Exhibit 102: GlaxoSmithKline Plc - Key news
Exhibit 103: GlaxoSmithKline Plc - Key offerings
Exhibit 104: GlaxoSmithKline Plc - Segment focus
10.9 Immunogenics LLC
Exhibit 105: Immunogenics LLC - Overview
Exhibit 106: Immunogenics LLC - Product / Service
Exhibit 107: Immunogenics LLC - Key offerings
10.10 Johnson and Johnson
Exhibit 108: Johnson and Johnson - Overview
Exhibit 109: Johnson and Johnson - Business segments
Exhibit 110: Johnson and Johnson - Key news
Exhibit 111: Johnson and Johnson - Key offerings
Exhibit 112: Johnson and Johnson - Segment focus
10.11 Sanofi
Exhibit 113: Sanofi - Overview
Exhibit 114: Sanofi - Business segments
Exhibit 115: Sanofi - Key news
Exhibit 116: Sanofi - Key offerings
Exhibit 117: Sanofi - Segment focus
10.12 Takeda Pharmaceutical Co. Ltd.
Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key offerings

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 122: Inclusions checklist
Exhibit 123: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 124: Currency conversion rates for US$
11.4 Research methodology
Exhibit 125: Research methodology
Exhibit 126: Validation techniques employed for market sizing
Exhibit 127: Information sources
11.5 List of abbreviations
Exhibit 128: List of abbreviations
health: Includes veterinary drugs (excluded from the scope of the report)

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Therapy - Market share 2021-2026 (%)
Exhibits25: Data Table on Therapy - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Therapy
Exhibits27: Data Table on Comparison by Therapy
Exhibits28: Chart on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on First line treatment - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on First line treatment - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Second line treatment - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Second line treatment - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Therapy ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Amgen Inc. - Overview
Exhibits86: Amgen Inc. - Product / Service
Exhibits87: Amgen Inc. - Key offerings
Exhibits88: AMYRA Biotech AG - Overview
Exhibits89: AMYRA Biotech AG - Product / Service
Exhibits90: AMYRA Biotech AG - Key offerings
Exhibits91: BioLineRx Ltd. - Overview
Exhibits92: BioLineRx Ltd. - Product / Service
Exhibits93: BioLineRx Ltd. - Key offerings
Exhibits94: Bristol Myers Squibb Co. - Overview
Exhibits95: Bristol Myers Squibb Co. - Product / Service
Exhibits96: Bristol Myers Squibb Co. - Key offerings
Exhibits97: Calypso Biotech - Overview
Exhibits98: Calypso Biotech - Product / Service
Exhibits99: Calypso Biotech - Key offerings
Exhibits100: GlaxoSmithKline Plc - Overview
Exhibits101: GlaxoSmithKline Plc - Business segments
Exhibits102: GlaxoSmithKline Plc - Key news
Exhibits103: GlaxoSmithKline Plc - Key offerings
Exhibits104: GlaxoSmithKline Plc - Segment focus
Exhibits105: Immunogenics LLC - Overview
Exhibits106: Immunogenics LLC - Product / Service
Exhibits107: Immunogenics LLC - Key offerings
Exhibits108: Johnson and Johnson - Overview
Exhibits109: Johnson and Johnson - Business segments
Exhibits110: Johnson and Johnson - Key news
Exhibits111: Johnson and Johnson - Key offerings
Exhibits112: Johnson and Johnson - Segment focus
Exhibits113: Sanofi - Overview
Exhibits114: Sanofi - Business segments
Exhibits115: Sanofi - Key news
Exhibits116: Sanofi - Key offerings
Exhibits117: Sanofi - Segment focus
Exhibits118: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits121: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits122: Inclusions checklist
Exhibits123: Exclusions checklist
Exhibits124: Currency conversion rates for US$
Exhibits125: Research methodology
Exhibits126: Validation techniques employed for market sizing
Exhibits127: Information sources
Exhibits128: List of abbreviations

この商品のレポートナンバー

0000032854

TOP